SCHEMBL13401110

SCHEMBL13401110

NNCCCCOCc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.50
CYP3A4 P08684 3/20 0.48
IDO1 P14902 3/20 0.48
ALDH1A1 P00352 2/20 0.48
LMNA P02545 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
NPC1 O15118 1/20 0.48
KDM1A O60341 1/20 0.48
CYP1A2 P05177 1/20 0.48
HTR1A P08908 1/20 0.48
ADRA2A P08913 1/20 0.48
CYP2C8 P10632 1/20 0.48
CYP2D6 P10635 1/20 0.48
CYP2C9 P11712 1/20 0.48
NFKB1 P19838 1/20 0.48
MAOA P21397 1/20 0.48
PTGS1 P23219 1/20 0.48
SLC6A2 P23975 1/20 0.48
MAOB P27338 1/20 0.48
CYP2C19 P33261 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3489737 0.98 TSHR (0.48) TSHRCYP3A4IDO1ALDH1A1LMNA
SCHEMBL11129540 0.94 TSHR (0.52) TSHRCYP3A4IDO1ALDH1A1LMNA
SCHEMBL15701190 0.86 TSHR (0.56) TSHRCYP3A4IDO1ALDH1A1LMNA
Hydrochloric Acid SCHEMBL11129793 0.85 TSHR (0.54) TSHRCYP3A4IDO1ALDH1A1LMNA
SCHEMBL16620502 0.85 TSHR (0.54) TSHRLMNASMN1; SMN2NPC1MAOA
SCHEMBL2640223 0.84 TSHR (0.70) TSHRIDO1L3MBTL1TDP1EPHX2
SCHEMBL9011595 0.82 TSHR (0.67) TSHRIDO1LMNASMN1; SMN2L3MBTL1
SCHEMBL9011734 0.82 TSHR (0.67) TSHRIDO1SMN1; SMN2L3MBTL1TDP1
SCHEMBL9011715 0.82 TSHR (0.67) TSHRIDO1SMN1; SMN2L3MBTL1TDP1
SCHEMBL9011624 0.82 TSHR (0.67) TSHRIDO1SMN1; SMN2L3MBTL1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100094000-A1 PYRAZOLE COMPOUNDS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-04-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100094000-A1 PYRAZOLE COMPOUNDS NR3C2, MC2R, NR3C1 TSHR 75/4885CYP3A4 454/4885IDO1 3157/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.